Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06842875 · ClinicalTrials.gov registry record · NA
Rhode Island - Statewide Postpartum Hypertension Remote Surveillance
A NA study of Hypertension in Pregnancy and Postpartum Preeclampsia, sponsored by Women and Infants Hospital of Rhode Island.
- Recruiting
- Registry status
- NA
- Development phase
- 1,536
- Enrollment target
- 5
- Study locations
NCT06842875: Recruiting NA study of Hypertension in Pregnancy and Postpartum Preeclampsia, sponsored by Women and Infants Hospital of Rhode Island.
NCT06842875 is a NA study of Hypertension in Pregnancy and Postpartum Preeclampsia that is actively recruiting participants, run by Women and Infants Hospital of Rhode Island. The registered enrollment target is 1,536 participants, above the 330-participant average among 13 other Hypertension in Pregnancy trials with a reported enrollment target (365% higher). The trial reports 5 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06842875, a NA study of Hypertension in Pregnancy and Postpartum Preeclampsia, is actively recruiting participants, sponsored by Women and Infants Hospital of Rhode Island.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,536 participants
- Enrollment target
- 5
- Study locations
Study Summary
This is a hybrid type 1 non-inferiority implementation effectiveness trial among postpartum patients with hypertension (N=1536) that will test the hypothesis that RI-SPHERES (a technologically enabled collaborative care model) is non-inferior to a standard self-measured blood pressure program in terms of persistent hypertension at six weeks postpartum and preventive care receipt within one year of delivery.
Primary Outcome
Persistent stage II hypertension will be defined as systolic blood pressure of 140 mmHg or higher and/or diastolic blood pressure of 90 mmHg or higher
Conditions Studied
Interventions
- BEHAVIORAL RI-SPHERES
- BEHAVIORAL Standard self-measured blood pressure program
Study Locations (5)
Rhode Island
- Newport Hospital - Newport
- Women & Infants Hospital of Rhode Island - Providence
- South County Hospital - Wakefield
- Kent Hospital - Warwick
- Landmark Hospital - Woonsocket
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,536 participants |
| Start Date | 2025-04-15 |
| Est. Completion | 2029-03-01 |
| Phase | NA |
What NCT06842875 shows while recruiting
NCT06842875 is an interventional study that assigns participants to a tested intervention. Its 1,536 participants enrollment target places it among the larger protocols in the corpus, above the 330-participant average among 13 other Hypertension in Pregnancy trials with a reported enrollment target (365% higher).
The record links to 3 conditions, with Hypertension in Pregnancy appearing as the primary indexed condition, and to 2 interventions - of which RI-SPHERES is the first listed.
NCT06842875 lists 5 locations in 1 state (Rhode Island).
Frequently Asked Questions
What is clinical trial NCT06842875 about?
NCT06842875 is a clinical study titled "Rhode Island - Statewide Postpartum Hypertension Remote Surveillance". This is a hybrid type 1 non-inferiority implementation effectiveness trial among postpartum patients with hypertension (N=1536) that will test the hypothesis that RI-SPHERES (a technologically enabled collaborative care model) is non-inferior to a standard self-measured blood pressure program in ter...
What is the current status of trial NCT06842875?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,536 participants. The study started on 2025-04-15. Estimated completion is 2029-03-01.
What conditions does trial NCT06842875 study?
This clinical trial studies the following conditions: Hypertension in Pregnancy, Postpartum Preeclampsia, Postpartum Complication.
What interventions are being tested in trial NCT06842875?
The interventions under investigation include: RI-SPHERES (BEHAVIORAL), Standard self-measured blood pressure program (BEHAVIORAL).
Who is sponsoring clinical trial NCT06842875?
This trial is sponsored by Women and Infants Hospital of Rhode Island, which has 65 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06842875 being conducted?
This trial has 5 study locations across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension in Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06842875's enrollment target sits among peer trials
1,536 1st of 13 higher than 13 of 13 other Hypertension in Pregnancy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypertension in Pregnancy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients
RECRUITING · NA
-
Moms@Home: A Storytelling-based Mobile Health Intervention to Improve Blood Pressure Management in Pregnancy
RECRUITING · NA
-
Mobile Health Interventions to Prevent Heart Disease After Hypertensive Disorders of Pregnancy
RECRUITING · NA
-
Mindfulness & Mechanisms Study
ACTIVE NOT RECRUITING · NA
-
Deep Breathing Techniques (Pranayama) in Pregnancy
COMPLETED · NA
-
Innovation in Postpartum Care for Women With Hypertensive Disorders of Pregnancy
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03435796 · 1,541 participants · Phase 2
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- NCT06393374 · 1,530 participants · Phase 3
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
- NCT07114510 · 1,530 participants · NA
Optimal Ventilation for Cardiac Arrest
- NCT06623097 · 1,528 participants · NA
Exercise and Nutrition for Older Cancer Survivors and Their Support Person: The Vitality Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI